摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cis-octahydro-5-oxo-1(2H)-quinolinecarboxylic acid 1,1-dimethylethyl ester | 98218-81-6

中文名称
——
中文别名
——
英文名称
cis-octahydro-5-oxo-1(2H)-quinolinecarboxylic acid 1,1-dimethylethyl ester
英文别名
cis-1-(tert-butoxycarbonyl)-5-oxodecahydroquinoline;tert-butyl (4aR,8aR)-5-oxo-2,3,4,4a,6,7,8,8a-octahydroquinoline-1-carboxylate
cis-octahydro-5-oxo-1(2H)-quinolinecarboxylic acid 1,1-dimethylethyl ester化学式
CAS
98218-81-6;115689-55-9
化学式
C14H23NO3
mdl
——
分子量
253.342
InChiKey
QBCOZLWLOUVNAA-GHMZBOCLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    359.5±25.0 °C(Predicted)
  • 密度:
    1.086±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    46.6
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    cis-octahydro-5-oxo-1(2H)-quinolinecarboxylic acid 1,1-dimethylethyl ester氧气 、 palladium diacetate 、 lithium hexamethyldisilazane 作用下, 以 四氢呋喃二甲基亚砜 为溶剂, 反应 20.0h, 生成
    参考文献:
    名称:
    合成和DFT研究朝着统一的方型生物碱生物碱:导致5-氧代邻苯二酚喹啉的Aza-Michael分子内过程
    摘要:
    描述了一种非对映选择性的顺式-5-氧代十二氢喹啉合成方法,其中在一个反应​​罐中生成了三个立体中心。该反应涉及由非手性无环甲苯磺胺系β-酮酯促成的氢氧化锂促进的罗宾逊环化/分子内氮杂-迈克尔多米诺过程。通过使用基于DFT的机理研究,促进了该反应的发展和范围,使合理的非对映异构化过程得以观察到。发现所得十氢喹啉的立体化学和稳定性的变化取决于是否将β-酮酸酯或酮嵌入进行氨基环化的底物中。这种合成方法不仅可以同时获得两个非对映异构体的顺式通过相应的N未取代的顺式-5-氧代十二氢喹啉的差向异构化过程,可从相同的前体得到十氢喹啉,也可将其转变为相应的反式异构体。所描述的方法提供了高级构建基块,其中包含了完全合成Phlegmarine生物碱所需的三个相对立体化学。
    DOI:
    10.1002/chem.201301715
  • 作为产物:
    参考文献:
    名称:
    Nitrones by heterolytic fragmentation of .gamma.-N-hydroxyamino sulfonates. Conversion of a decahydroquinoline to a perhydroazaazulene
    摘要:
    DOI:
    10.1021/jo00220a057
点击查看最新优质反应信息

文献信息

  • Azabicyclic compounds are central nervous system active agents
    申请人:Dart J. Michael
    公开号:US20060287290A1
    公开(公告)日:2006-12-21
    Compounds of formula (I) are novel CNS active agents that are useful for treating pain and for treating other disorders associated with the cholinergic system.
    式(I)的化合物是一种新型的中枢神经系统活性剂,可用于治疗疼痛以及与胆碱能系统相关的其他疾病的治疗。
  • Dopamine autoreceptor agonists as potential antipsychotics. 3. 6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine
    作者:Bradley W. Caprathe、Juan C. Jaen、Lawrence D. Wise、Thomas G. Heffner、Thomas A. Pugsley、Leonard T. Meltzer、Masood Parvez
    DOI:10.1021/jm00113a010
    日期:1991.9
    A series of rigid tricyclic analogues of the dopamine (DA) agonist PD 118440 [4-(1,2,5,6-tetrahydro-1-propyl-3-pyridinyl)-2-thiazolamine] was synthesized and evaluated for dopaminergic activity and DA autoreceptor selectivity. (R)-(+)-6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine ((+)-6) was identified as the most selective DA autoreceptor agonist from this group of compounds. It inhibited spontaneous locomotor activity (LMA) in rodents, reversed the gamma-butyrolactone (GBL) induced accumulation of rat striatal DOPA and inhibited brain DA neuronal firing, all suggestive of direct DA autoreceptor agonist activity. However, (+)-6 is not completely free of postsynaptic DA activity, as evidenced by its stimulation of LMA in rats at high doses and its ability to produce stereotypy. On the other hand, (-)-6 appears to be a weak partial DA agonist with some effects on brain DA synthesis only at high doses. Like other DA autoreceptor agonists and DA antagonists, (+)-6 inhibited Sidman conditioned avoidance in squirrel monkeys, a test predictive of clinical antipsychotic activity. However, unlike classical antipsychotics, (+)-6 did not induce dystonias in haloperidol-sensitized squirrel monkeys, suggesting a minimal propensity toward extrapyramidal side effects (EPS).
  • CAPRATHE, BRADLEY W.;JAEN, JUAN C.;WISE, LAWRENCE D.
    作者:CAPRATHE, BRADLEY W.、JAEN, JUAN C.、WISE, LAWRENCE D.
    DOI:——
    日期:——
  • LEBEL, N. A.;CAPRATHE, B. W., J. ORG. CHEM., 1985, 50, N 20, 3938-3940
    作者:LEBEL, N. A.、CAPRATHE, B. W.
    DOI:——
    日期:——
  • Nitrones by heterolytic fragmentation of .gamma.-N-hydroxyamino sulfonates. Conversion of a decahydroquinoline to a perhydroazaazulene
    作者:Norman A. LeBel、Bradley W. Caprathe
    DOI:10.1021/jo00220a057
    日期:1985.10
查看更多

同类化合物

锯齿石松宁 箭毒蛙毒素 C 坎库碘铵 十氢喹啉 十氢-2-甲基喹啉 八氢对苯二酚-4(1H)-酮 八氢喹啉-2(1H)-酮 八氢-2,6-喹啉二酮 [(4aS,4bR,6aS,8S,10aS,10bS,12aS)-10a,12a-二甲基-1,2,3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-十六氢萘并[6,5-f]喹啉-8-基]2-[4-[二(2-氯乙基)氨基]苯基]乙酸酯 [(4aS,4bR,6aS,8S,10aS,10bS,12aS)-1,10a,12a-三甲基-2-氧代-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-十四氢萘并[6,5-f]喹啉-8-基]2-[4-[二(2-氯乙基)氨基]苯基]乙酸酯 8H-13,3,6a-乙基亚基-7,10-亚甲基噁庚并[3,4-i]-1-苯并吖辛因-8-酮,1-乙基十四氢-12a-羟基-6-甲氧基-3-甲基-,(3R,6S,6aS,7R,7aS,10S,12aS,13S,13aR,15R)-(9CI) 8-羟基-十氢喹啉 4-乙炔基-2-甲基十氢喹啉-4-醇 3-羟基-13,17-开环-5-雄甾烯-17-酸-13,17-内酰胺(4-(二(2-氯乙基)氨基)苯基)丁酸酯 2,5-二丙基十氢喹啉 1-(3-氯-丙基)-十氢-喹啉 1,2,2-三甲基-八氢-喹啉-4-酮 (4aS,4bR,8S,10aR,10bS,12aS)-10a,12a-二甲基-2-羰基-1,2,3,4,4a,4b,5,7,8,9,10,10a,10b,11,12,12a-十六氢萘并[2,1-f]喹啉-8-基{4-[二(2-氯乙基)氨基]苯基}乙酸酯 (4aS,4bR,6aS,8S,10aS,10bS,12aS)-8-羟基-10a,12a-二甲基-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-十四氢-1H-萘并[2,1-f]喹啉-2-酮 (3S,13R)-1,2,3,4,4aalpha,5,11,11aalpha-八氢-2,2,5-三甲基-3beta,5beta-乙桥-10bH-吡啶并[3,2-b]咔唑-10bbeta,13-二醇 (3R,6S,6aS,7R,7aS,10S,12aS,13R,13aR,14S,15R)-1-乙基十四氢-12a,14-二羟基-6-甲氧基-3-甲基-8H-13,3,6a-亚乙基-7,10-甲桥氧杂卓并[3,4-i]-1-苯并氮杂环辛四烯-8-酮 (2S,4aR,8aR)-2-甲基八氢-4(1H)-喹啉酮 (2R,4R,4As,8As)-rel-4-乙炔基十氢-1,2-二甲基-4-喹啉醇 (4aS,5R,8aR)-1-(tert-butoxy)carbonyl-2-oxo-5-(triisopropylsilyloxymethyl)decahydroquinoline trans-(+/-)-1-n-propyl-7-oxodecahydroquinoline 3,4,5,6,6a,7,8,9,10,10a-decahydro-(4aβH)-benzo[c]quinolizin-3-one 3,4,5,6,6a,7,8,9,10,10a-decahydro-(4aαH)-benzo[c]quinolizin-3-one 3,4,4a,5,6,7,8-heptahydro-8a-hydrodioxy-2(1H)-quinolinone [2-(2,3-dichloro-phenyl)-thiazol-4-yl]-(octahydro-quinolin-1-yl)-methanone (octahydro-quinolin-1-yl)-(2-pyridin-3-yl-thiazol-4-yl)-methanone 2-methylperhydrothiazolo<2,3-j>quinoline 2,4-dichloro-N-[5-((4aRS,8aSR)-octahydroquinoline-1-carbonyl)pyridin-2-yl]benzamide (4aR*,5S*,8aR*)-1,2,3,4,4a,5,6,7,8,8a-Decahydro-5-<(dimethylphenylsilyl)methyl>-1-methylquinoline (4aS*,5S*,8aR*)-1,2,3,4,4a,5,6,7,8,8a-Decahydro-5-<(dimethylphenylsilyl)methyl>-1-(methoxycarbonyl)quinoline (2S,3R,4aS,5R,8aR)-1-(tert-butoxy)carbonyl-3-hydroxy-2-methyl-5-(triisopropylsilyloxymethyl)decahydroquinoline (+/-)-(2SR,4aRS,8aRS)-1-tert-butyloxycarbonyl-5-methylene-2-propyldecahydroquinoline (+/-)-(2SR,4aRS,8aRS)-1-tert-butyloxycarbonyl-2-propyldecahydroquinolin-5-one cis-4-[4-(octahydro-quinoline-1(2H)-ylcarbonyl)-thiophen-2-yl]-piperidine-1-carboxylic acid amide lepadin E (+)-lepadin D cis-(octahydro-quinolin-1(2H)-yl)-(5-piperidin-4-yl-thiophen-3-yl)-methanone 4-methyl-6-(3-methyl-2-thienyl)-4,5,6,7-tetrahydroquinolin-5-one 2,2,4,8-tetramethyldecahydroquinoline 10-oxo-2,5;5,9-diseco-A-dinor-strychnidine-2,5-dioic acid strychnidine-2,3,10-trione 3-tetrazolo-17a-aza-D-homo-3,5-androstadien-17-one 17a-methyl-3-tetrazolo-17a-aza-D-homo-3,5-androstadien-17-one methyl 4-oxooctahydroquinoline-1(2H)-carboxylate decahydro-2-oxo-8-quinolinepropanoic acid ethyl ester 1-octahydro[1]quinolyl-propan-2-ol